Parvoduk

RSS

Lapsed

This medicine's authorisation has lapsed

live attenuated Muscovy duck parvovirus
MedicineVeterinaryLapsed

Maltese is available via eTranslation, the European Commission's machine translation service.

Translate to Maltese | Important information about machine translation

  • Application under evaluation
  • CVMP opinion
  • European Commission decision

Overview

The marketing authorisation for Parvoduk has lapsed because it has not been marketed in the European Union in the three years following the granting of the authorisation.

български (BG) (279.17 KB - PDF)

Ara

español (ES) (388.86 KB - PDF)

Ara

čeština (CS) (432.85 KB - PDF)

Ara

dansk (DA) (386.36 KB - PDF)

Ara

Deutsch (DE) (392.74 KB - PDF)

Ara

eesti (ET) (372.5 KB - PDF)

Ara

ελληνικά (EL) (456.39 KB - PDF)

Ara

français (FR) (390.28 KB - PDF)

Ara

hrvatski (HR) (547.54 KB - PDF)

Ara

italiano (IT) (391.31 KB - PDF)

Ara

latviešu (LV) (456.12 KB - PDF)

Ara

lietuvių (LT) (421.48 KB - PDF)

Ara

magyar (HU) (449.76 KB - PDF)

Ara

Malti (MT) (440.69 KB - PDF)

Ara

Nederlands (NL) (388.36 KB - PDF)

Ara

polski (PL) (432.82 KB - PDF)

Ara

português (PT) (389.06 KB - PDF)

Ara

română (RO) (418.94 KB - PDF)

Ara

slovenčina (SK) (436.71 KB - PDF)

Ara

slovenščina (SL) (428.53 KB - PDF)

Ara

suomi (FI) (387.48 KB - PDF)

Ara

svenska (SV) (386.11 KB - PDF)

Ara

Product information

български (BG) (1.19 MB - PDF)

Ara

español (ES) (804.6 KB - PDF)

Ara

čeština (CS) (1.03 MB - PDF)

Ara

dansk (DA) (817.13 KB - PDF)

Ara

Deutsch (DE) (901.86 KB - PDF)

Ara

eesti (ET) (803.72 KB - PDF)

Ara

ελληνικά (EL) (1.2 MB - PDF)

Ara

français (FR) (816.73 KB - PDF)

Ara

hrvatski (HR) (1.23 MB - PDF)

Ara

italiano (IT) (816.1 KB - PDF)

Ara

latviešu (LV) (1.05 MB - PDF)

Ara

lietuvių (LT) (953.35 KB - PDF)

Ara

magyar (HU) (997.58 KB - PDF)

Ara

Malti (MT) (1.06 MB - PDF)

Ara

Nederlands (NL) (808.14 KB - PDF)

Ara

polski (PL) (1.17 MB - PDF)

Ara

português (PT) (803.42 KB - PDF)

Ara

română (RO) (936.44 KB - PDF)

Ara

slovenčina (SK) (1.06 MB - PDF)

Ara

slovenščina (SL) (1.06 MB - PDF)

Ara

suomi (FI) (791.59 KB - PDF)

Ara

svenska (SV) (796.96 KB - PDF)

Ara

Íslenska (IS) (803.26 KB - PDF)

Ara

norsk (NO) (815.13 KB - PDF)

Ara
Latest procedure affecting product information:R/0006
09/01/2019

български (BG) (189.97 KB - PDF)

Ara

español (ES) (281.53 KB - PDF)

Ara

čeština (CS) (304.72 KB - PDF)

Ara

dansk (DA) (298.36 KB - PDF)

Ara

Deutsch (DE) (302.28 KB - PDF)

Ara

eesti (ET) (285.5 KB - PDF)

Ara

ελληνικά (EL) (325.92 KB - PDF)

Ara

français (FR) (335.93 KB - PDF)

Ara

hrvatski (HR) (307.68 KB - PDF)

Ara

italiano (IT) (299.37 KB - PDF)

Ara

latviešu (LV) (340.5 KB - PDF)

Ara

lietuvių (LT) (297.31 KB - PDF)

Ara

magyar (HU) (303.78 KB - PDF)

Ara

Malti (MT) (306.38 KB - PDF)

Ara

Nederlands (NL) (313.36 KB - PDF)

Ara

polski (PL) (299.63 KB - PDF)

Ara

português (PT) (297.7 KB - PDF)

Ara

română (RO) (312.51 KB - PDF)

Ara

slovenčina (SK) (304.5 KB - PDF)

Ara

slovenščina (SL) (297.92 KB - PDF)

Ara

suomi (FI) (295.81 KB - PDF)

Ara

svenska (SV) (293.03 KB - PDF)

Ara

Íslenska (IS) (292.58 KB - PDF)

Ara

norsk (NO) (298.06 KB - PDF)

Ara

Product details

Name of medicine
Parvoduk
Active substance
live attenuated Muscovy duck parvovirus
International non-proprietary name (INN) or common name
live attenuated Muscovy duck parvovirus
Species
Ducks
Anatomical therapeutic chemical veterinary (ATCvet) code
QI01BD03

Pharmacotherapeutic group

  • duck parvovirus
  • Live viral vaccines
  • Immunologicals for aves

Therapeutic indication

Active immunisation of ducks to prevent mortality1 and to reduce weight loss and lesions of duck parvovirosis and Derzsy's disease.


1In absence of maternally derived antibodies.

Authorisation details

EMA product number
EMEA/V/C/002740
Marketing authorisation holder
Merial

29 Avenue Tony Garnier
69007 Lyon
France

Marketing authorisation issued
11/04/2014
Lapse of marketing authorisation
01/04/2019
Revision
2

Assessment history

This page was last updated on

Share this page